FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:2399-2406 December 18, 2003 Number 25 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by Hahn, B. H. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

ABSTRACT

Background Although systemic lupus erythematosus is associated with premature myocardial infarction, the prevalence of underlying atherosclerosis and its relation to traditional risk factors for cardiovascular disease and lupus-related factors have not been examined in a case–control study.

Methods In 197 patients with lupus and 197 matched controls, we performed carotid ultrasonography, echocardiography, and an assessment for risk factors for cardiovascular disease. The patients were also evaluated with respect to their clinical and serologic features, inflammatory mediators, and disease treatment.

Results The risk factors for cardiovascular disease were similar among patients and controls. Atherosclerosis (carotid plaque) was more prevalent among patients than the controls (37.1 percent vs. 15.2 percent, P<0.001). In multivariate analysis, only older age, the presence of systemic lupus erythematosus (odds ratio, 4.8; 95 percent confidence interval, 2.6 to 8.7), and a higher serum cholesterol level were independently related to the presence of plaque. As compared with patients without plaque, patients with plaque were older, had a longer duration of disease and more disease-related damage, and were less likely to have multiple autoantibodies or to have been treated with prednisone, cyclophosphamide, or hydroxychloroquine. In multivariate analyses including patients with lupus, independent predictors of plaque were a longer duration of disease, a higher damage-index score, a lower incidence of the use of cyclophosphamide, and the absence of anti-Smith antibodies.

Conclusions Atherosclerosis occurs prematurely in patients with systemic lupus erythematosus and is independent of traditional risk factors for cardiovascular disease. The clinical profile of patients with lupus and atherosclerosis suggests a role for disease-related factors in atherogenesis and underscores the need for trials of more focused and effective antiinflammatory therapy.

Source Information

From the Divisions of Cardiology (M.J.R., R.B.D.), Rheumatology (B.-A.S., A.D., M.D.L., L.S., M.K.C., S.A.P., J.E. Salmon), and Hematology–Oncology (R.S.), Weill Medical College of Cornell University, the Hospital for Special Surgery, New York; and the Department of Psychiatry, State University of New York at Stony Brook, Stony Brook (J.E. Schwartz).

Address reprint requests to Dr. Roman at the Division of Cardiology, Weill Medical College of Cornell University, 525 E. 68th St., New York, NY 10021, or at mroman{at}med.cornell.edu.

Full Text of this Article

Related Letters:

Premature Coronary Disease in Systemic Lupus
Wurzel J., Goldman B. I., Doria A., Shoenfeld Y., Pauletto P., Violi F., Loffredo L., Ferro D., Pezzetta F., Mascitelli L., Noël B., Roman M. J., Lockshin M. D., Salmon J. E., Stein C. M., Hahn B. H.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:1571-1575, Apr 8, 2004. Correspondence

This article has been cited by other articles:

• Roldan, C. A (2008). Valvular and coronary heart disease in systemic inflammatory diseases: Systemic Disorders in heart disease. Heart 94: 1089-1101 [Full Text]  
• Mathieu, S., Joly, H., Baron, G., Tournadre, A., Dubost, J.-J., Ristori, J.-M., Lusson, J.-R., Soubrier, M. (2008). Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease. Rheumatology (Oxford) 47: 1203-1207 [Abstract] [Full Text]  
• Wright, S A, O'Prey, F M, McHenry, M T, Leahey, W J, Devine, A B, Duffy, E M, Johnston, D G, Finch, M B, Bell, A L, McVeigh, G E (2008). A randomised interventional trial of {omega}-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis 67: 841-848 [Abstract] [Full Text]  
• Gasparyan, A. Y., Watson, T., Lip, G. Y.H. (2008). The Role of Aspirin in Cardiovascular Prevention: Implications of Aspirin Resistance. J Am Coll Cardiol 51: 1829-1843 [Abstract] [Full Text]  
• Frostegard, J (2008). Systemic lupus erythematosus and cardiovascular disease. Lupus 17: 364-367 [Abstract]  
• Hahn, B., McMahon, M (2008). Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies. Lupus 17: 368-370 [Abstract]  
• Hettema, M. E., Bootsma, H., Kallenberg, C. G. M. (2008). Macrovascular disease and atherosclerosis in SSc. Rheumatology (Oxford) 47: 578-583 [Abstract] [Full Text]  
• Nojima, J., Masuda, Y., Iwatani, Y., Kuratsune, H., Watanabe, Y., Suehisa, E., Takano, T., Hidaka, Y., Kanakura, Y. (2008). Arteriosclerosis obliterans associated with anti-cardiolipin antibody / {beta}2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus. Rheumatology (Oxford) 47: 684-689 [Abstract] [Full Text]  
• Ruiz-Irastorza, G, Khamashta, M. (2008). Hydroxychloroquine: the cornerstone of lupus therapy. Lupus 17: 271-273  
• Siso, A, Ramos-Casals, M, Bove, A, Brito-Zeron, P, Soria, N, Munoz, S, Testi, A, Plaza, J, Sentis, J, Coca, A (2008). Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survival. Lupus 17: 281-288 [Abstract]  
• Shoenfeld, Y., Meroni, P. L., Cervera, R. (2008). Antiphospholipid syndrome dilemmas still to be solved: 2008 status. Ann Rheum Dis 67: 438-442 [Full Text]  
• Telles, R., Lanna, C., Ferreira, G., Souza, A., Navarro, T., Ribeiro, A. (2008). Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting. Lupus 17: 105-113 [Abstract]  
• Lee, S-S., Singh, S., Magder, L., Petri, M. (2008). Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus 17: 114-123 [Abstract]  
• van Leuven, S. I., Franssen, R., Kastelein, J. J., Levi, M., Stroes, E. S. G., Tak, P. P. (2008). Systemic inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford) 47: 3-7 [Abstract] [Full Text]  
• Roman, M. J., Salmon, J. E. (2007). Cardiovascular Manifestations of Rheumatologic Diseases. Circulation 116: 2346-2355 [Full Text]  
• Martinez-Berriotxoa, A., Ruiz-Irastorza, G., Egurbide, M.-V., Garmendia, M., Gabriel Erdozain, J., Villar, I., Aguirre, C. (2007). Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Lupus 16: 810-816 [Abstract]  
• de Leeuw, K., Graaff, R., de Vries, R., Dullaart, R. P., Smit, A. J., Kallenberg, C. G., Bijl, M. (2007). Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus. Rheumatology (Oxford) 46: 1551-1556 [Abstract] [Full Text]  
• Nived, O., Andersson, M., Lindgren, M., Malcus-Johnsson, P., Nihlberg, A., Nived, K., Reimer-Rasmusson, G., Sturfelt, G., Stahl-Hallengren, C., Bengtsson, A.A. (2007). Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: A study with a questionnaire. Lupus 16: 701-706 [Abstract]  
• Bhatt, S., Handa, R., Gulati, G., Sharma, S., Pandey, R., Aggarwal, P., Ramakrishnan, L., Shankar, S. (2007). Peripheral vascular disease in systemic lupus erythematosus. Lupus 16: 720-723 [Abstract]  
• GIBSON, W. T., HAYDEN, M. R. (2007). Mycophenolate Mofetil and Atherosclerosis: Results of Animal and Human Studies. Ann. N. Y. Acad. Sci. 1110: 209-221 [Abstract] [Full Text]  
• Ardoin, S., Sandborg, C., Schanberg, L. (2007). Review: Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. Lupus 16: 618-626 [Abstract]  
• Ranchin, B., Fargue, S. (2007). Review: New treatment strategies for proliferative lupus nephritis: keep children in mind!. Lupus 16: 684-691 [Abstract]  
• LOPEZ, L. R., BUCKNER, T. R., HURLEY, B. L., KOBAYASHI, K., MATSUURA, E. (2007). Determination of Oxidized Low-Density Lipoproteins (ox-LDL) versus ox-LDL/beta2GPI Complexes for the Assessment of Autoimmune-Mediated Atherosclerosis. Ann. N. Y. Acad. Sci. 1109: 303-310 [Abstract] [Full Text]  
• Knockaert, D. C. (2007). Cardiac involvement in systemic inflammatory diseases. Eur Heart J 28: 1797-1804 [Abstract] [Full Text]  
• O'Neill, S. G, Isenberg, D. A, Rahman, A. (2007). Could antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus?. Ann Rheum Dis 66: 989-991 [Full Text]  
• Pieretti, J., Roman, M. J., Devereux, R. B., Lockshin, M. D., Crow, M. K., Paget, S. A., Schwartz, J. E., Sammaritano, L., Levine, D. M., Salmon, J. E. (2007). Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass. Circulation 116: 419-426 [Abstract] [Full Text]  
• Der, H., Kerekes, G., Veres, K., Szodoray, P., Toth, J., Lakos, G., Szegedi, G., Soltesz, P. (2007). Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus 16: 497-503 [Abstract]  
• Methe, H., Weis, M. (2007). Atherogenesis and inflammation--was Virchow right?. Nephrol Dial Transplant 22: 1823-1827 [Full Text]  
• Gautier, E. L., Huby, T., Ouzilleau, B., Doucet, C., Saint-Charles, F., Gremy, G., Chapman, M. J., Lesnik, P. (2007). Enhanced Immune System Activation and Arterial Inflammation Accelerates Atherosclerosis in Lupus-Prone Mice. Arterioscler. Thromb. Vasc. Bio. 27: 1625-1631 [Abstract] [Full Text]  
• Edwards, N. C., Ferro, C. J., Townend, J. N., Steeds, R. P. (2007). Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance. Rheumatology (Oxford) 46: 1208-1209 [Full Text]  
• TANAY, A., LEIBOVITZ, E., FRAYMAN, A., ZIMLICHMAN, R., GAVISH, D. (2007). Vascular Elasticity of Systemic Lupus Erythematosus Patients Is Associated with Steroids and Hydroxychloroquine Treatment. Ann. N. Y. Acad. Sci. 1108: 24-34 [Abstract] [Full Text]  
• COLOMBO, B. M., MURDACA, G., CAITI, M., RODRIGUEZ, G., GRASSIA, L., ROSSI, E., INDIVERI, F., PUPPO, F. (2007). Intima-Media Thickness: A Marker of Accelerated Atherosclerosis in Women with Systemic Lupus Erythematosus. Ann. N. Y. Acad. Sci. 1108: 121-126 [Abstract] [Full Text]  
• Ahmad, Y., Shelmerdine, J., Bodill, H., Lunt, M., Pattrick, M. G., Teh, L. S., Bernstein, R. M., Walker, M. G., Bruce, I. N. (2007). Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype. Rheumatology (Oxford) 46: 983-988 [Abstract] [Full Text]  
• Ait-Oufella, H., Kinugawa, K., Zoll, J., Simon, T., Boddaert, J., Heeneman, S., Blanc-Brude, O., Barateau, V., Potteaux, S., Merval, R., Esposito, B., Teissier, E., Daemen, M. J., Leseche, G., Boulanger, C., Tedgui, A., Mallat, Z. (2007). Lactadherin Deficiency Leads to Apoptotic Cell Accumulation and Accelerated Atherosclerosis in Mice. Circulation 115: 2168-2177 [Abstract] [Full Text]  
• Korkmaz, C., Cansu, D.U., Kasifoglu, T. (2007). Myocardial infarction in young patients (<=35 years of age) with systemic lupus erythematosus: a case report and clinical analysis of the literature. Lupus 16: 289-297 [Abstract]  
• Feng, X., Li, H., Rumbin, A. A., Wang, X., La Cava, A., Brechtelsbauer, K., Castellani, L. W., Witztum, J. L., Lusis, A. J., Tsao, B. P. (2007). ApoE-/-Fas-/- C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia. J. Lipid Res. 48: 794-805 [Abstract] [Full Text]  
• Paran, D., Caspi, D., Levartovsky, D., Elkayam, O., Kaufman, I., Litinsky, I., Keren, G., Koifman, B. (2007). Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis 66: 506-510 [Abstract] [Full Text]  
• Haubitz, M (2007). Exploring new territory: the move towards individualised treatment. Lupus 16: 227-231 [Abstract]  
• Chung, C. P, Avalos, I., Oeser, A., Gebretsadik, T., Shintani, A., Raggi, P., Michael Stein, C (2007). High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66: 208-214 [Abstract] [Full Text]  
• Kavey, R.-E. W., Allada, V., Daniels, S. R., Hayman, L. L., McCrindle, B. W., Newburger, J. W., Parekh, R. S., Steinberger, J. (2006). Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation 114: 2710-2738 [Abstract] [Full Text]  
• Sin, D. D., Anthonisen, N. R., Soriano, J. B., Agusti, A. G. (2006). Mortality in COPD: role of comorbidities. Eur Respir J 28: 1245-1257 [Abstract] [Full Text]  
• Szekanecz, Z, Shoenfeld, Y (2006). Lupus and cardiovascular disease: the facts. Lupus 15: 3-10 [Abstract]  
• Bruce, I N (2006). The influence of other drugs on coronary heart disease (CHD) risk in systemic lupus erythematosus. Lupus 15: 23-26 [Abstract]  
• La Rosa, J C (2006). Atherosclerotic vascular disease in systemic lupus erythematosus and related disorders. Lupus 15: 35-38 [Abstract]  
• Davies, R J, Sangle, S R, Khamashta, M A, D'Cruz, D P (2006). Antiphospholipid (Hughes) syndrome and atheroma. Lupus 15: 55-58 [Abstract]  
• McMahon, M, Grossman, J, Chen, W, Hahn, B H (2006). Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus. Lupus 15: 59-69 [Abstract]  
• Sinclair, A, Baildon, R (2006). Mycophenolate mofetil: an overview. Lupus 15: 70-77  
• De Leeuw, K, Freire, B, Smit, A J, Bootsma, H, Kallenberg, C G, Bijl, M (2006). Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. Lupus 15: 675-682 [Abstract]  
• Li, S. C. (2006). Lipid Abnormalities in Children with Systemic Lupus Erythematosus (SLE). AAP Grand Rounds 16: 45-46 [Full Text]  
• Wright, S. A., O'Prey, F. M., Rea, D. J., Plumb, R. D., Gamble, A. J., Leahey, W. J., Devine, A. B., McGivern, R. C., Johnston, D. G., Finch, M. B., Bell, A. L., McVeigh, G. E. (2006). Microcirculatory Hemodynamics and Endothelial Dysfunction in Systemic Lupus Erythematosus. Arterioscler. Thromb. Vasc. Bio. 26: 2281-2287 [Abstract] [Full Text]  
• Tincani, A., Rebaioli, C. B., Taglietti, M., Shoenfeld, Y. (2006). Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 45: iv8-iv13 [Abstract] [Full Text]  
• Ruiz-Irastorza, G, Egurbide, M-V, Pijoan, J-I, Garmendia, M, Villar, I, Martinez-Berriotxoa, A, Erdozain, J-G, Aguirre, C (2006). Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15: 577-583 [Abstract]  
• Seyahi, E, Ugurlu, S, Cumali, R, Balci, H, Seyahi, N, Yurdakul, S, Yazici, H (2006). Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 65: 1202-1207 [Abstract] [Full Text]  
• Roman, M. J, Naqvi, T. Z, Gardin, J. M, Gerhard-Herman, M., Jaff, M., Mohler, E. (2006). American Society of Echocardiography Report: Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med 11: 201-211  
• Crouse, J. R. III (2006). Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art. J. Lipid Res. 47: 1677-1699 [Abstract] [Full Text]  
• Salmon, J. E., Paget, S. A., Roman, M. J. (2006). Carotid Atherosclerosis and Rheumatoid Arthritis.. ANN INTERN MED 145: 231-231 [Full Text]  
• Dahl, A, Omdal, R, Waterloo, K, Joakimsen, O, Jacobsen, E A, Koldingsnes, W, Mellgren, S I (2006). Detection of cerebral embolic signals in patients with systemic lupus erythematosus. J. Neurol. Neurosurg. Psychiatry 77: 774-779 [Abstract] [Full Text]  
• Stanic, A. K., Stein, C. M., Morgan, A. C., Fazio, S., Linton, M. F., Wakeland, E. K., Olsen, N. J., Major, A. S. (2006). Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 103: 7018-7023 [Abstract] [Full Text]  
• D'Cruz, D. P (2006). Systemic lupus erythematosus.. BMJ 332: 890-894 [Full Text]  
• Mannino, D. M., Watt, G., Hole, D., Gillis, C., Hart, C., McConnachie, A., Davey Smith, G., Upton, M., Hawthorne, V., Sin, D. D., Man, S. F. P., Van Eeden, S., Mapel, D. W., Vestbo, J. (2006). The natural history of chronic obstructive pulmonary disease.. Eur Respir J 27: 627-643 [Full Text]  
• van Leuven, S I, Kastelein, J J., D'Cruz, D P, Hughes, G R, Stroes, E S (2006). Atherogenesis in rheumatology. Lupus 15: 117-121 [Abstract]  
• Roman, M. J., Moeller, E., Davis, A., Paget, S. A., Crow, M. K., Lockshin, M. D., Sammaritano, L., Devereux, R. B., Schwartz, J. E., Levine, D. M., Salmon, J. E. (2006). Preclinical carotid atherosclerosis in patients with rheumatoid arthritis.. ANN INTERN MED 144: 249-256 [Abstract] [Full Text]  
• Shaw, L. J., Bairey Merz, C. N., Pepine, C. J., Reis, S. E., Bittner, V., Kelsey, S. F., Olson, M., Johnson, B. D., Mankad, S., Sharaf, B. L., Rogers, W. J., Wessel, T. R., Arant, C. B., Pohost, G. M., Lerman, A., Quyyumi, A. A., Sopko, G., for the WISE Investigators, (2006). Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies. J Am Coll Cardiol 47: S4-S20 [Abstract] [Full Text]  
• Lopez, L R, Salazar-Paramo, M, Palafox-Sanchez, C, Hurley, B L, Matsuura, E, Garcia-De La Torre, I (2006). Oxidized low-density lipoprotein and {beta}2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis. Lupus 15: 80-86 [Abstract]  
• Huerta, P. T., Kowal, C., DeGiorgio, L. A., Volpe, B. T., Diamond, B. (2006). Immunity and behavior: Antibodies alter emotion. Proc. Natl. Acad. Sci. USA 103: 678-683 [Abstract] [Full Text]  
• Tse, K C, Li, F K, Tang, S, Tang, C S-O, Lai, K N, Chan, T M (2005). Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria. Lupus 14: 947-952 [Abstract]  
• Hall, F. C., Dalbeth, N. (2005). Disease modification and cardiovascular risk reduction: two sides of the same coin?. Rheumatology (Oxford) 44: 1473-1482 [Abstract] [Full Text]  
• Bruce, I. N. (2005). 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 44: 1492-1502 [Abstract] [Full Text]  
• Mineo, C., Gormley, A. K., Yuhanna, I. S., Osborne-Lawrence, S., Gibson, L. L., Hahner, L., Shohet, R. V., Black, S., Salmon, J. E., Samols, D., Karp, D. R., Thomas, G. D., Shaul, P. W. (2005). Fc{gamma}RIIB Mediates C-Reactive Protein Inhibition of Endothelial NO Synthase. Circ. Res. 97: 1124-1131 [Abstract] [Full Text]  
• Shoenfeld, Y., Gerli, R., Doria, A., Matsuura, E., Cerinic, M. M., Ronda, N., Jara, L. J., Abu-Shakra, M., Meroni, P. L., Sherer, Y. (2005). Accelerated Atherosclerosis in Autoimmune Rheumatic Diseases. Circulation 112: 3337-3347 [Full Text]  
• Tso, T K, Huang, W-N, Huang, H-Y, Chang, C-K (2005). Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus. Lupus 14: 878-883 [Abstract]  
• Cardoso, C R., Sales, M A., Papi, J A., Salles, G F (2005). QT-interval parameters are increased in systemic lupus erythematosus patients. Lupus 14: 846-852 [Abstract]  
• Feinbloom, D., Bauer, K. A. (2005). Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events. Arterioscler. Thromb. Vasc. Bio. 25: 2043-2053 [Abstract] [Full Text]  
• Pinn, V. W. (2005). Research on Women's Health: Progress and Opportunities. JAMA 294: 1407-1410 [Full Text]  
• Tincani, A, Biasini-Rebaioli, C, Cattaneo, R, Riboldi, P (2005). Nonorgan specific autoantibodies and heart damage. Lupus 14: 656-659 [Abstract]  
• Doria, A, Iaccarino, L, Sarzi-Puttini, P, Atzeni, F, Turriel, M, Petri, M (2005). Cardiac involvement in systemic lupus erythematosus. Lupus 14: 683-686 [Abstract]  
• Bruce, I N (2005). Atherogenesis and autoimmune disease: the model of lupus. Lupus 14: 687-690 [Abstract]  
• Tenedios, F, Erkan, D, Lockshin, M D (2005). Cardiac involvement in the antiphospholipid syndrome. Lupus 14: 691-696 [Abstract]  
• Frostegard, J. (2005). Atherosclerosis in Patients With Autoimmune Disorders. Arterioscler. Thromb. Vasc. Bio. 25: 1776-1785 [Abstract] [Full Text]  
• Calvo-Alen, J., Alarcon, G. S., Campbell, R. Jr, Fernandez, M., Reveille, J. D., Cooper, G. S. (2005). Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology (Oxford) 44: 1186-1189 [Abstract] [Full Text]  
• Barnes, E V, Narain, S, Naranjo, A, Shuster, J, Segal, M S, Sobel, E S, Armstrong, A E, Santiago, B E, Reeves, W H, Richards, H B (2005). High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus 14: 576-582 [Abstract]  
• Binstadt, B. A., Levine, J. C., Nigrovic, P. A., Gauvreau, K., Dedeoglu, F., Fuhlbrigge, R. C., Weindling, S. N., Newburger, J. W., Sundel, R. P. (2005). Coronary Artery Dilation Among Patients Presenting With Systemic-Onset Juvenile Idiopathic Arthritis. Pediatrics 116: e89-e93 [Abstract] [Full Text]  
• Szalai, A. J., Alarcon, G. S., Calvo-Alen, J., Toloza, S. M. A., McCrory, M. A., Edberg, J. C., McGwin, G. Jr, Bastian, H. M., Fessler, B. J., Vila, L. M., Kimberly, R. P., Reveille, J. D., for the LUMINA Study Group, (2005). Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events. Rheumatology (Oxford) 44: 864-868 [Abstract] [Full Text]  
• Roman, M. J., Devereux, R. B., Schwartz, J. E., Lockshin, M. D., Paget, S. A., Davis, A., Crow, M. K., Sammaritano, L., Levine, D. M., Shankar, B.-A., Moeller, E., Salmon, J. E. (2005). Arterial Stiffness in Chronic Inflammatory Diseases. Hypertension 46: 194-199 [Abstract] [Full Text]  
• Buyon, J. P., Petri, M. A., Kim, M. Y., Kalunian, K. C., Grossman, J., Hahn, B. H., Merrill, J. T., Sammaritano, L., Lockshin, M., Alarcon, G. S., Manzi, S., Belmont, H. M., Askanase, A. D., Sigler, L., Dooley, M. A., Von Feldt, J., McCune, W. J., Friedman, A., Wachs, J., Cronin, M., Hearth-Holmes, M., Tan, M., Licciardi, F. (2005). The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial. ANN INTERN MED 142: 953-962 [Abstract] [Full Text]